Condition

Dystrophic Epidermolysis Bullosa clinical trials and research

• 7Clinical trials
• 9Countries

Newest Dystrophic Epidermolysis Bullosa clinical trials

All recruiting trials (7)

• Energy-F703EB Cream for Epidermolysis Bullosa: a skin cream test in adults

  This phase 2 study tests ENERGI-F703EB Cream versus a matching vehicle to see if it is safe and helps small EB skin lesions in adults.

  Recruiting Phase 2 Energenesis Biomedical Co., Ltd. · Tainan · NCT07858422

• Ev.FV to heal wounds in dystrophic epidermolysis bullosa

  This trial will test whether Ev.FV, a mesenchymal stem cell-derived extracellular vesicle therapy, helps heal wounds in people with dystrophic epidermolysis bullosa.

  Recruiting Phase 1/2 Isfahan University of Medical Sciences · Isfahan · NCT07230223

• KB803 eye drops versus placebo for people with dystrophic epidermolysis bullosa

  This trial tests whether KB803 eye drops, given three times a week, can reduce recurrent corneal abrasions in children and adults with dystrophic epidermolysis bullosa.

  Recruiting at 5 sites Phase 3 Krystal Biotech, Inc. · Rancho Santa Margarita, California and 4 other locations · NCT07016750

• Using IV immunoglobulin to lower collagen VII antibodies in dystrophic epidermolysis bullosa

  This trial tests whether IV immunoglobulin given to people with recessive dystrophic epidermolysis bullosa who are on VYJUVEK helps wounds heal faster and lowers collagen VII and HSV‑1 antibody levels.

  Recruiting Phase 1/2 Stanford University · Redwood City, California · NCT06834035

• Topical TCP-25 gel to help heal wounds in epidermolysis bullosa

  This trial tests whether applying TCP-25 gel to matched skin wounds helps improve healing in children and adults with dystrophic or junctional epidermolysis bullosa.

  Recruiting at 12 sites Phase 2 Xinnate AB · Cincinnati, Ohio and 12 other locations · NCT06594393

• Long-term follow-up for gene therapy in skin conditions

  This study is checking the long-term safety of a gene therapy for people with a skin condition called dystrophic epidermolysis bullosa who have already received the treatment.

  Recruiting at 3 sites Krystal Biotech, Inc. · Rancho Santa Margarita, California and 2 other locations · NCT04917887

• Using stem cell-derived exosomes to treat wounds in Dystrophic Epidermolysis Bullosa

  This study is testing whether a new treatment made from stem cells can help heal stubborn wounds in people with Dystrophic Epidermolysis Bullosa.

  Recruiting at 3 sites Phase 1/2 Aegle Therapeutics · Phoenix, Arizona and 2 other locations · NCT04173650

Related topics

Quick answers

How many Dystrophic Epidermolysis Bullosa clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (5 trials), Iran (1 trial), Taiwan (1 trial), France (1 trial), Greece (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →